Medpace (MEDP) closed at $521.21, up +1.34%, outperforming the S&P 500. Shares rose 3.31% in the past month. Earnings report on Oct 22, 2025, expects EPS of $3.5 and revenue of $640.45 million. Zacks Rank #3 (Hold). Forward P/E ratio is 36.65, PEG ratio 3.23. Industry Rank 96 in Medical sector.

The AI explosion’s 2nd wave presents wealth opportunities for investors. Zacks’ AI Boom 2.0 report identifies 4 companies poised for growth. Get the free report for insights. Initial AI stocks may plateau, making room for new innovators. Stay informed on stock movements with Zacks.com.

For more information, you can access the Free Stock Analysis Report on Medpace Holdings, Inc. (MEDP). Stay updated on key facts and market trends. Visit Zacks Investment Research for the latest recommendations and insights. Remember, Zacks’ Industry Rank and Zacks Rank can guide your investment decisions.

Read more at Nasdaq: Medpace (MEDP) Rises As Market Takes a Dip: Key Facts